Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$425K Buy
1,672
+510
+44% +$126K 0.1% 109
2020
Q2
$274K Buy
1,162
+42
+4% +$9.58K 0.07% 125
2020
Q1
$227K Sell
1,120
-47
-4% -$10.3K 0.06% 135
2019
Q4
$281K Buy
1,167
+4
+0.3% +$882 0.08% 135
2019
Q3
$225K Buy
+1,163
New +$223K 0.07% 144
2019
Q1
Sell
-1,071
Closed -$209K 149
2018
Q4
$209K Sell
1,071
-397
-27% -$77.5K 0.08% 128
2018
Q3
$304K Buy
1,468
+9
+0.6% +$1.77K 0.1% 103
2018
Q2
$269K Buy
+1,459
New +$258K 0.1% 110
2017
Q4
Sell
-1,089
Closed -$203K 117
2017
Q3
$203K Buy
+1,089
New +$193K 0.08% 119
2015
Q4
Sell
-1,798
Closed -$249K 85
2015
Q3
$249K Buy
+1,798
New +$283K 0.21% 68
2015
Q2
Sell
-1,326
Closed -$212K 80
2015
Q1
$212K Hold
1,326
0.11% 91
2014
Q4
$209K Buy
+1,326
New +$207K 0.1% 102

Other funds holding AMGN

FCG Advisors's AMGN Position: Q3 2020 in Review

FCG Advisors increased its Amgen (AMGN) stake by 44% in Q3 2020, buying an estimated $126K and bringing the position to 1,672 shares worth $425K. The position accounts for 0.1% of the portfolio, ranked #109.

FCG Advisors first reported a position in AMGN in Q4 2014 and has held it in 12 quarters since. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • FCG Advisors held 1,672 shares of Amgen worth $425K as of Q3 2020.
  • FCG Advisors bought 510 Amgen shares in Q3 2020, an estimated $126K.
  • Amgen made up 0.1% of FCG Advisors's portfolio in Q3 2020, its #109 holding.
  • FCG Advisors first reported a position in Amgen in Q4 2014 and has held it in 12 quarters since.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on FCG Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.